Antibiotics are instrumental for patients undergoing chemotherapy and surgery, and have paved the way for modern cancer care. Cancer patients often need antibiotics multiple times during the course of cancer treatment, which is why antibiotic resistance is seriously threatening patient outcomes. In ReAct’s new policy brief, you will learn more about the links connecting effective antibiotics and cancer care, and why urgent action on antibiotic resistance therefore is needed.
The threats imposed by antibiotic resistance on modern cancer care need to be articulated and included in global policy debates about antibiotic resistance. In ReAct’s new policy brief, you can read more about antibiotic resistance and cancer, and how cancer societies could be important actors of change by engaging in the issue.
Dr. Cary Adams, Chief Executive Officer, Union for International Cancer Control (UICC), says:
“Addressing antibiotic resistance is critical in improving cancer care outcomes globally and is a priority for UICC.
The time to address this issue is now, we therefore welcome ReAct’s work on highlighting the threat of antibiotic resistance in cancer care and look forward to working together in raising awareness on this issue and mobilize action towards change.
Furthermore, the lack of access in low resource settings and the excessive irrational use of antibiotics need to be addressed.”
Antibiotic resistance may limit the arsenal of cancer treatments
In the long run, antibiotic resistance may not only affect the possibilities of treating cancer patients’ infections, but also what kind of cancer treatment that can be offered. The risks of contracting resistant surgical site-infections must be weighed against the benefits of surgery, as would the risks of untreatable bloodstream infections have to be balanced against the benefits of chemotherapy. In fact, doctors in some countries need to do these type of analyses already today, as pointed out in an article published in Bloomberg in September last year. The article describes how cancer patients in India are faced with the impossible choice of either being treated for cancer and face a high risk of dying in an untreatable infection, or abstaining from treatment and risk dying from the cancer itself.
Effective antibiotics saved Alice’s life while she was treated for breast cancer
Alice needed chemotherapy. The therapy weakened her immune system and made it easier for bacteria to enter her bloodstream and she then needed antibiotics. This happened several times during her cancer treatment. Alice’s story was shared in a video (above) produced by British Society for Antimicrobial Chemotherapy (BSAC). Her story is unfortunately not unique. Severe infections are a common complication that often hit patients with cancer.
More news and opinion
- Nurse Dorce, Indonesia: Treating small patients with much love and infection prevention – a success story
- ReAct highlights during World Antimicrobial Awareness week 2020
- New ReAct film: Children at risk – The threat of antibiotic resistance
- Children at Risk: New ReAct film and global survey – ReAct’s asks of leaders!
- ReAct Asia Pacific: Winners of 2020 photography competition
- WAAW ReAct Africa: Engaging civil society and students
- WAAW in Indonesia: Focus on One Health approach to AMR
- Innovate4Health’s 32 finalist teams: For social innovations to address emerging infectious diseases!
- ReAct Open Letter: 5 key points to One Health Global Leaders Group on Antimicrobial Resistance
- New ReAct Report: Treatment of newborn sepsis is threatened – effective antibiotics essential
- Upcoming ReAct Africa Conference: What is the status of the NAPs on AMR in the African region?
- Animal welfare and antibiotic resistance in food animals
- ReAct activities for World Antimicrobial Awareness Week 2020
- Dr. Honar Cherif: My patients can recieve 5-10 courses of antibiotics during their cancer treatment
- New ReAct Report: Antibiotic resistance affects men and women differently
- ReAct Asia Pacific: Photo competition for students – health in focus
- 4 take aways from WHO’s first global report on sepsis
- Launch of global student design sprint – Innovate4Health
- World Sepsis Day – antibiotics essential in treatment of sepsis
- The new Pharmaceutical Strategy for Europe – an opportunity to put public interest first
- 4 key reflections on the recently launched WHO GLASS-report
- Key points from ReAct’s comments to the Independent Panel on Evidence
- ReAct Interview: From zoologist to community engagement on AMR
- ReAct Africa expands
- COVID-19 resolution – a missed opportunity to address global pandemic response more broadly
- What everyone needs to know about clinical research
- New ReAct Policy Brief: Successful cancer treatment relies on effective antibiotics
- Impact of COVID-19 on vaccine-preventable diseases and antibiotic resistance
- ReAct Africa and Africa CDC: COVID-19 webinars
- Antibiotic pollution: India scores a global first with effluent limits
- COVID-19 and AMR – what do we know so far?
- Learning from bedaquiline in South Africa – comprehensive health systems for new antibiotics
- ReAct Interview: How does antibiotics in food animal production end up in the environment?
- Key take aways from CSO workshop on AMR in Kenya
- New fact sheet: Effective antibiotics – essential for childrens’ survival
- Shortages and AMR – why should we care? 4 consequences of antibiotic shortages
- Our microbiome and noncommunicable diseases
- The 2020 AMR Benchmark Report – concerning findings with questionable framing
- 4 key reflections from engaging hospitals in India for antibiotic stewardship
- Teacher Gustavo Cedillo, Ecuador, teaches children about the bacterial world